Frumberg David B, Epstein Samantha E, Jauregui Julio J, Pivec Robert, Maheshwari Aditya V
Department of Orthopaedic Surgery and Rehabilitation Medicine, SUNY Downstate Medical Center/University Hospital Brooklyn, Brooklyn, NY, United States.
Harvard Medical School, Harvard University, Boston, MA, United States.
J Clin Orthop Trauma. 2016 Oct-Dec;7(Suppl 1):130-133. doi: 10.1016/j.jcot.2016.02.008. Epub 2016 Jun 9.
Periprosthetic infection following total hip arthroplasty is a devastating complication that has been reported to occur in up to 1.6% of all primary total hip arthroplasties. We report a previously unrecognized gram-negative bacillus as the infecting agent in a patient with bilateral total hip arthroplasties for stage IV osteonecrosis. A 22-year-old male with combined sickle cell disease and beta thalassemia with a prior history of unknown hip surgeries and treatment for distal tibial osteomyelitis in Africa developed a periprosthetic joint infection; intra-operative cultures confirmed the infecting organism to be which was sensitive to late-generation cephalosporins and vancomycin. He was successfully treated with a staged revision total hip arthroplasty with an antibiotic spacer and has been infection-free since. is a gram-negative bacillus which has not been previously associated with periprosthetic infection following TJA. This organism infects both humans and fish, and is particularly associated with commercial fishing and fish farming of freshwater and marine fish, potentially putting workers in these industries at risk. Little is known about antibacterial resistance in this organism. Infection by presents a new organism which may affect individuals undergoing TJA, particularly if they have medical comorbidities that increase their risk for infection, or work in industries which put them at a higher risk of infection by this organism. Further study on the antimicrobial resistance patterns of this organism will be required to be able to treat potentially resistant organisms.
全髋关节置换术后的假体周围感染是一种毁灭性的并发症,据报道在所有初次全髋关节置换术中发生率高达1.6%。我们报告了一例双侧全髋关节置换治疗IV期骨坏死患者,其感染病原体为一种此前未被识别的革兰氏阴性杆菌。一名22岁男性,患有镰状细胞病和β地中海贫血,既往有不明的髋关节手术史,曾在非洲接受过胫骨远端骨髓炎治疗,发生了假体周围关节感染;术中培养证实感染病原体为 ,该病原体对新一代头孢菌素和万古霉素敏感。他通过分期翻修全髋关节置换术加抗生素间隔物成功治愈,此后一直未发生感染。 是一种革兰氏阴性杆菌,此前尚未与全关节置换术后的假体周围感染相关联。这种微生物可感染人类和鱼类,尤其与淡水和海水鱼类的商业捕捞及水产养殖有关,可能使这些行业的工人面临风险。人们对这种微生物的抗菌耐药性知之甚少。 感染代表了一种可能影响接受全关节置换术患者的新病原体,特别是如果他们有增加感染风险的合并症,或从事使他们面临更高感染这种病原体风险的行业。需要对这种微生物的抗菌耐药模式进行进一步研究,以便能够治疗潜在的耐药微生物。